Search research articles
Contact Us
Filters
Showing results (191-200 of 204) with videos related to
Page
of 21
Sort By:
Nature Medicine
|
April 24, 2019
Utility of ctDNA to support patient selection for early phase clinical trials: the TARGET study
Dominic G Rothwell, Mahmood Ayub, Natalie Cook, et al.
Eclinicalmedicine
|
June 24, 2026
Cediranib with weekly paclitaxel or olaparib versus weekly paclitaxel for advanced or recurrent endometrial cancer (COPELIA): a multicentre, open-label, randomised, phase 2 trial in the UK
Robert D Morgan, Catharine Porter, Cong Zhou, et al.
Nature Communications
|
May 31, 2024
Representation of genomic intratumor heterogeneity in multi-region non-small cell lung cancer patient-derived xenograft models
Robert E Hynds, Ariana Huebner, David R Pearce, et al.
Cancer Discovery
|
February 11, 2026
Abrogation of Oncogenic RAS Signaling by a RAS(ON) Inhibitor Doublet Primes Immune-refractory KRAS G12C-mutant NSCLC for Immune Checkpoint Blockade
Xing Wei, Cristina Blaj, M Ali Al-Radhawi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
February 5, 2020
New Approaches to SCLC Therapy: From the Laboratory to the Clinic
John T Poirier, Julie George, Taofeek K Owonikoko, et al.
Plos Biology
|
July 9, 2014
Tracking genomic cancer evolution for precision medicine: the lung TRACERx study
Mariam Jamal-Hanjani, Alan Hackshaw, Yenting Ngai, et al.
Cancers
|
August 26, 2022
An International Comparison of Presentation, Outcomes and CORONET Predictive Score Performance in Patients with Cancer Presenting with COVID-19 across Different Pandemic Waves
Oskar Wysocki, Cong Zhou, Jacobo Rogado, et al.
JCO Clinical Cancer Informatics
|
May 24, 2022
Establishment of CORONET, COVID-19 Risk in Oncology Evaluation Tool, to Identify Patients With Cancer at Low Versus High Risk of Severe Complications of COVID-19 Disease On Presentation to Hospital
Rebecca J Lee, Oskar Wysocki, Cong Zhou, et al.
Nature
|
April 12, 2023
The evolution of non-small cell lung cancer metastases in TRACERx
Maise Al Bakir, Ariana Huebner, Carlos Martínez-Ruiz, et al.
The New England Journal of Medicine
|
April 27, 2017
Tracking the Evolution of Non-Small-Cell Lung Cancer
Mariam Jamal-Hanjani, Gareth A Wilson, Nicholas McGranahan, et al.
Page
of 21
Search research articles
Search
Showing results (191-200 of 204) with videos related to
Sort By:
Page
of 21
Nature Medicine
|
April 24, 2019
Utility of ctDNA to support patient selection for early phase clinical trials: the TARGET study
Dominic G Rothwell, Mahmood Ayub, Natalie Cook, et al.
Eclinicalmedicine
|
June 24, 2026
Cediranib with weekly paclitaxel or olaparib versus weekly paclitaxel for advanced or recurrent endometrial cancer (COPELIA): a multicentre, open-label, randomised, phase 2 trial in the UK
Robert D Morgan, Catharine Porter, Cong Zhou, et al.
Nature Communications
|
May 31, 2024
Representation of genomic intratumor heterogeneity in multi-region non-small cell lung cancer patient-derived xenograft models
Robert E Hynds, Ariana Huebner, David R Pearce, et al.
Cancer Discovery
|
February 11, 2026
Abrogation of Oncogenic RAS Signaling by a RAS(ON) Inhibitor Doublet Primes Immune-refractory KRAS G12C-mutant NSCLC for Immune Checkpoint Blockade
Xing Wei, Cristina Blaj, M Ali Al-Radhawi, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
February 5, 2020
New Approaches to SCLC Therapy: From the Laboratory to the Clinic
John T Poirier, Julie George, Taofeek K Owonikoko, et al.
Plos Biology
|
July 9, 2014
Tracking genomic cancer evolution for precision medicine: the lung TRACERx study
Mariam Jamal-Hanjani, Alan Hackshaw, Yenting Ngai, et al.
Cancers
|
August 26, 2022
An International Comparison of Presentation, Outcomes and CORONET Predictive Score Performance in Patients with Cancer Presenting with COVID-19 across Different Pandemic Waves
Oskar Wysocki, Cong Zhou, Jacobo Rogado, et al.
JCO Clinical Cancer Informatics
|
May 24, 2022
Establishment of CORONET, COVID-19 Risk in Oncology Evaluation Tool, to Identify Patients With Cancer at Low Versus High Risk of Severe Complications of COVID-19 Disease On Presentation to Hospital
Rebecca J Lee, Oskar Wysocki, Cong Zhou, et al.
Nature
|
April 12, 2023
The evolution of non-small cell lung cancer metastases in TRACERx
Maise Al Bakir, Ariana Huebner, Carlos Martínez-Ruiz, et al.
The New England Journal of Medicine
|
April 27, 2017
Tracking the Evolution of Non-Small-Cell Lung Cancer
Mariam Jamal-Hanjani, Gareth A Wilson, Nicholas McGranahan, et al.
Page
of 21